Pregna-1,4-diene-3,20-dione, 16,21-bis(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11β,16α)-;
9-Fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate [67-78-7]
BRIEFING
Triamcinolone Diacetate. This proposal is based on the version of the monograph official as of May 1, 2020. The following changes are being proposed:
-
This monograph will be recategorized from a USP monograph to a Global Health (GH) monograph on the targeted official date of February 1, 2028. This monograph is used for essential purposes in other parts of the world.
-
No drug products formulated with Triamcinolone Diacetate are currently marketed in the United States.
Additionally, minor editorial changes have been made to update the monograph to current USP style. No changes to tests have been made.
(SM5: S. Cusick)
Case ID—SUB-2550